User menu

Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease.

Bibliographic reference Ibrahim, S. ; Derde, M P ; Kaufman, L. ; Clerckx-Braun, F ; Jacqmin, P. ; et. al. Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease.. In: Renal failure, Vol. 12, no. 3, p. 199-203 (1990)
Permanent URL http://hdl.handle.net/2078.1/24774
  1. Price K E, Aminoglycoside research 1975-1985: prospects for development of improved agents., 10.1128/aac.29.4.543
  2. Lietman PS, Principles and practice of infectious diseases, pp 192 (1985)
  3. Frame P. T., Phair J. P., Watanakunakorn C., Bannister T. W. P., Pharmacologic Factors Associated with Gentamicin Nephrotoxicity in Rabbits, 10.1093/infdis/135.6.952
  4. Bennett W. M., Plamp C. E., Gilbert D. N., Parker R. A., Porter G. A., The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal Failure, 10.1093/infdis/140.4.576
  5. Wood C. A., Norton D. R., Kohlhepp S. J., Kohnen P. W., Porter G. A., Houghton D. C., Brummett R. E., Bennett W. M., Gilbert D. N., The Influence of Tobramycin Dosage Regimens on Nephrotoxicity, Ototoxicity, and Antibacterial Efficacy in a Rat Model of Subcutaneous Abscess, 10.1093/infdis/158.1.13
  6. Tran Ba Huy P, J Drug Dev, 1, 93 (1988)
  7. Craig W A, JDrug Dev, 1, 7 (1988)
  8. Tulkens Paul M., Experimental studies on nephrotoxicity of aminoglycosides at low doses: Mechanisms and perspectives, 10.1016/0002-9343(86)90487-0
  9. Tulkens P.M., Nephrotoxicity of aminoglycoside antibiotics, 10.1016/0378-4274(89)90121-5
  10. Ibrahim S., Van der Auwera P., Meunier F., Tulkens P. M., Effect of Netilmicin and Amikacin on Urinary Phospholipids Excretion in Humans, Archives of Toxicology (1989) ISBN:9783540503361 p.413-416, 10.1007/978-3-642-74117-3_81
  11. Sawchuk R J, JPharma cokinetBiopharm, 4, 183 (1976)
  12. Sawchuk Ronald J., Zaske Darwin E., Cipolle Robert J., Wargin William A., Strate Richard G., Kinetic model for gentamicin dosing with the use of individual patient parameters, 10.1002/cpt1977213362
  13. Schentag JJ, The Aminoglycosides: microbiology, clinical use and toxicology, pp 143 (1982)
  14. Hollender L. F., Bahnini J., Manzini N. De, Lau W. Y., Fan S. T., Hermansyur K., Benny P., Husni A. N., Sutjipto, Lorber R. R., A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections, 10.1093/jac/23.5.773
  15. Sturm A. W., Netilmicin in the Treatment of Gram-Negative Bacteremia: Single Daily versus Multiple Daily Dosage, 10.1093/infdis/159.5.931
  16. Brummett R E, Fox K E, Aminoglycoside-induced hearing loss in humans., 10.1128/aac.33.6.797